Documents

孙辉 体外诊断医保收费与卫生技术评估的进展与思考-SH (For sharing).pdfdownload
第四位嘉宾-汪祺.pptxdownload

Home

Join us for a Healthcare Policy Forum hosted by the Healthcare Committee on May 28, 2024, from 1:30 PM to 5:00 PM, at the AmCham Shanghai Conference Center. The forum will delve into the latest medical policies and provide a dynamic opportunity for healthcare industry leaders to deeply engage and discuss with policymakers and experts in innovative pharmaceuticals and other sectors.


欢迎参加上海美国商会医疗政策解读研讨会,与我们一起全面探索中国的医疗行业前景。本次研讨会将于5月28日(周二)下午13:30 - 17:00在上海美国商会会议中心举行。


医疗政策解读研讨会旨在为医疗行业的企业会员提供一个深入了解和探讨《政府工作报告》中提出的创新药物等领域最新政策的机会。会议将涵盖促进三医协同发展和治理,持续深化医药卫生体制改革、上海市促进生物医药产业发展政策、中国医疗行业现状及创新机遇、《生物安全法》解读、体外诊断收费与HTA研究等当前行业热点议题,期望通过政策解读,为参与者提供政策层面的深刻洞察和实践指导,共同探索行业发展的新机遇。


Agenda 会议日程:

13:30 开幕致辞 - 韦春艳,上海美国商会医疗委员会主席

13:40 促进三医协同发展和治理,持续深化医药卫生体制改革 - 许树强,国家卫健委体改司原司长、中国医院发展研究院院长

14:20 上海市促进生物医药产业发展政策 - 陈敦副处长 徐文恺,上海市科委生物医药产业推进工作组

14:40 中国医疗行业现状及创新机遇 - 张畅,艾昆纬中国管理咨询部高级总监

15:00 《生物安全法》解读 - 汪祺,安可咨询大中华区首席运营官

15:20 茶歇

15:40 体外诊断收费与HTA研究 - 孙辉,上海市卫生技术评估研究中心

16:00 圆桌讨论:医疗生态合作讨论

彭庆,上海生物医药产业股权投资基金投资总监

罗念慈,上海黄浦健贤医疗行业创新研究院院长

李丽,菲鹏集团资本生态高级总监

韦春艳,丹纳赫集团对外事务副总裁

17:00 会议闭幕


Event language: Chinese

Please note the event will be conducted in Chinese.

Speakers

  • Shuqiang Xu (Dean/Former Director of Chinese Hospital Development Research Institute/Health Reform Department of the National Health Commission of China)

    Shuqiang Xu

    Dean/Former Director of Chinese Hospital Development Research Institute/Health Reform Department of the National Health Commission of China

    许树强,现任上海交通大学讲席教授、第十三届校务委员会副主任,中国医院发展研究院院长。医学硕士、法学博士、经济学博士后。教授、主任医师、博士生导师。中国医师协会副会长,中国卫生经济学会副会长,中国卫生经济学会公立医院高质量发展分会(筹)会长, 中国研究型医院学会副会长,中国灾害防御协会副会长,中国灾害防御协会医疗卫生应急分会(筹)会长。

    长期从事医疗卫生健康领域的研究与管理实践,致力于深化医药卫生体制改革政策设计与推进实施,在医改发展阶段、医改难点问题、医改实践路径等理论实践方面,提出了创新的观点和行之有效的举措。

    view more
  • Chang Zhang (Senior Principal, Management Consulting at IQVIA China)

    Chang Zhang

    Senior Principal, Management Consulting at IQVIA China

    Mr. Zhang is a senior leader of IQVIA China’s management consulting team, focusing on pharmaceutical, medical technologies, and healthcare services industries. With over 17 years of experience he advises leading multinational and Chinese corporations as well as government bodies, NGOs and investment funds in critical value-generation topics such as strategic planning and choices, transactions, business and portfolio development.

    Mr. Zhang received his bachelor degree in pharmacology at Wuhan University and holds Master degrees in biochemistry (University of Paris - Saclay) and marketing (HEC Paris Grande Ecole). He previously served EY-Parthenon, Oliver Wyman - OC&C, and Roland Berger, among others.

    张畅先生是艾昆纬管理咨询高级总监,专注于医药,医疗器械,医疗服务等大健康领域的管理咨询;在战略规划、企业交易、业务发展领域有超过17年经验,为政府和非政府组织、央企与国企、跨国企业、民营集团与企业、投资基金等提供价值增长支持。

    张畅先生毕业于武汉大学(药学学士)、巴黎大学(萨克雷,生物化学硕士)、HEC巴黎高等商学院(管理学硕士);曾供职安永-帕特侬、奥纬-欧析、罗兰贝格等咨询机构。

    view more
  • Anne Wang (Chief Operating Officer, Greater China at APCO)

    Anne Wang

    Chief Operating Officer, Greater China at APCO

    Ms. Anne Wang is the Chief Operating Officer for APCO Greater China region. She has over 18 years of rich experience in the healthcare sector to advise multinational corporations on their public affairs and advocacy strategies in the China market.

    Ms. Anne Wang oversees the business operation in the Greater China region for APCO, a global advisory and advocacy firm helping leading corporations, foundations and governments navigate a complex world. Throughout the years, she has been dedicated to fuse the best local experience with a global perspective and has built a diverse and experienced consultant team with a unique culture. In the past 10 years, Ms. Anne Wang led the company’s healthcare practice in the Greater China region and has been providing briefing and counselling on China’s macro-economic and healthcare industrial policies to global and China management teams of multinational companies as well as trade and industrial associations.

    Before joining APCO, Ms. Anne Wang worked as a senior project officer in the Health Human Resources Development Center of China's National Health Commission, where she was responsible for international cooperation, policy research and capacity building programs through coordination with various partners including foreign embassies, multinational companies, international universities, and research institutions.

    Ms. Anne Wang holds a bachelor’s degree in clinical medicine from Tianjin Medical University and completed a master's in psychology program at the University of Essex in U.K.

    view more
  • HS

    Hui Sun

    Researcher at Shanghai Health Technology Assessment Research Center

  • QP

    Qing Peng

    Investment Director of Shanghai Healthcare Capital

  • Nianci Luo (Director of Shanghai Huangpu Jianxian Medical Industry Innovation Research Institute)

    Nianci Luo

    Director of Shanghai Huangpu Jianxian Medical Industry Innovation Research Institute

    罗念慈先生,曾任华润JCI医院管理研究院(中国)院长、总经理, BSI(英国标准协会)中国咨询培训公司总经理,同时在上海交通大学、南京大学EMBA、杜克(昆山)大学等知名院校担任医疗健康管理领域客座讲师、教授。
    罗先生在医疗管理领域拥有20年丰富经验,专精于医疗领域战略、运营管理体系、质量与安全及领导力发展。
    当前领导上海健贤研究院,与知名医疗机构深度合作,从事产医融合下的医疗科研成果转化工作,尤其对以临床重大需求为导向的临床资源、科研资源与产业技术平台的深度跨领域合作创新有丰富经验。

    view more
  • Li Li (Senior Director of Capital Ecosystem at FAPON)

    Li Li

    Senior Director of Capital Ecosystem at FAPON

  • Anita Wei (VP, Public Affairs at Danaher China)

    Anita Wei

    VP, Public Affairs at Danaher China

    Anita Wei is currently the VP for Government Affairs at Danaher China.

    Before this role, she was the Senior Director Public Affairs & Communications for BD Greater China and Head of Communications for Novartis Pharma Greater China.

    Anita obtained her bachelor’s degree in economics from University of International Business and Economics in Beijing and her Master Degree in Marketing and Communications from University of Sydney.

    Anita Wei serves as the Vice Chair of AmCham Shanghai's Healthcare Committee.

    view more

Tickets

A prepayment is required when choosing 'Standard Price'.

“标准票价”要求您在提交注册信息后即刻完成在线预付,若您希望在活动现场支付门票,请选择“现场票价”。
Member Ticket

Definition of a Member: You are personally registered as a member and hold a membership card.

Member Price RMB 600
Member Company Employee Ticket
Standard Price RMB 800
Non-Member Ticket
Standard Price RMB 1,200

Venue

AmCham Shanghai Conference Center

27F, Infinitus Tower

No.168 Hubin Road, Huangpu District
新天地湖滨路168号无限极大厦27楼

Shanghai, China

If you have any questions please contact Kelly Deng

Contact Organizer

Show on map